FREE Account Opening + No Clearing Fees
Loading...

Esconet Technologies IPO vs Zenith Drugs IPO

Comparision between Esconet Technologies IPO and Zenith Drugs IPO.

IPO Details

Esconet Technologies IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Book Built Issue proposed to list at NSE SME.

  Esconet Technologies IPO Zenith Drugs IPO
Logo Esconet Technologies IPO Logo Zenith Drugs IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Corporate Capitalventures Pvt Ltd Gretex Corporate Services Limited
Registrar Skyline Financial Services Private Ltd Bigshare Services Pvt Ltd
Market Maker Ss Corporate Securities Limited Gretex Share Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Esconet Technologies IPO is up to ₹28.22 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹40.68 Cr. The final issue price of Esconet Technologies IPO is ₹84.00 per share and of Zenith Drugs IPO is ₹79.00 per share.

  Esconet Technologies IPO Zenith Drugs IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹80.00 per share ₹75.00 per share
Issue Price (Upper) ₹84.00 per share ₹79.00 per share
Issue Price (Final) ₹84.00 per share ₹79.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 1600 shares
Fresh Issue Size 33,60,000 shares 51,48,800 shares
Fresh Issue Size (Amount) up to ₹28.22 Cr up to ₹40.68 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 33,60,000 shares 51,48,800 shares
Issue Size Total (Amount) up to ₹28.22 Cr up to ₹40.68 Cr

IPO Timetable

Esconet Technologies IPO opens on Feb 16, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Esconet Technologies IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.

  Esconet Technologies IPO Zenith Drugs IPO
Anchor Bid Date Feb 15, 2024 Feb 16, 2024
Issue Open Feb 16, 2024 Feb 19, 2024
Issue Close Feb 20, 2024 Feb 22, 2024
Basis Of Allotment (Tentative) Feb 21, 2024 Feb 23, 2024
Initiation of Refunds (Tentative) Feb 22, 2024 Feb 26, 2024
Credit of Share (Tentative) Feb 22, 2024 Feb 26, 2024
Listing date (Tentative) Feb 23, 2024 Feb 27, 2024
Anchor Lockin End date 1 Mar 22, 2024 Mar 24, 2024
Anchor Lockin End date 2 May 21, 2024 May 23, 2024

Financials

Esconet Technologies IPO P/E ratio is 24.87, as compared to Zenith Drugs IPO P/E ratio of 18.4.

  Esconet Technologies IPO Zenith Drugs IPO
Financial

Esconet Technologies Limited Financial Information (Restated Consolidated)

Period Ended30 Sep 202331 Mar 2023
Assets4,260.462,798.37
Revenue7,146.719,690.84
Profit After Tax305.47304.00
Net Worth902.97554.47
Reserves and Surplus825.19477.48
Total Borrowing1,008.951,103.89
Amount in ₹ Lakhs

Zenith Drugs Limited Financial Information (Restated Consolidated)

Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Sep 202331 Mar 202331 Mar 2022
Assets11,249.049,793.836,858.47
Revenue6,948.4311,569.659,266.63
Profit After Tax539.38515.29312.86
Net Worth2,264.961,724.421,209.09
Reserves and Surplus1,064.961,684.421,169.09
Total Borrowing2,902.812,605.031,880.86
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 89.18% 100.00%
Promoter Shareholding (Post-Issue) 64.94% 69.98%
P/E Ratio 24.87 18.4
Market Cap ₹103.82 Cr. ₹135.48 Cr.
ROE 75.54%% 35.13%%
ROCE 59.11%% 37.29%%
Debt/Equity 1.99 1.51
EPS ₹39.63 ₹4.29
RoNW 54.83%% 29.88%%

Shares Offered

In the Esconet Technologies IPO retail investors (RII) are offered 11,15,200 shares while in Zenith Drugs IPO retail investors are offered 11,15,200 shares. Qualified institutional buyers (QIB) are offered 6,36,800 shares in Esconet Technologies IPO and 8,59,200 shares in Zenith Drugs IPO.

  Esconet Technologies IPO Zenith Drugs IPO
Anchor Investor Reserveration 9,53,600 shares 12,88,000 shares
Market Maker Reserveration 1,76,000 shares 8,52,800 shares
QIB 6,36,800 shares 8,59,200 shares
NII 4,78,400 shares 6,44,800 shares
RII 11,15,200 shares 15,04,000 shares
Employee 0 shares 0 shares
Others
Total 22,30,400 shares 30,08,000 shares

Bids Received (Subscription)

Esconet Technologies IPO subscribed 507.24x in total, whereas Zenith Drugs IPO subscribed 179.18x.

  Esconet Technologies IPO Zenith Drugs IPO
QIB (times) 156.02x 106.72x
NII (times) 868.05x 368.77x
Big NII (times)
Small NII (times)
RII (times) 553.02x 139.28x
Employee (times)
Other (times)
Total (times) 507.24x 179.18x

Comments

Add a public comment...